Psychedelic-Assisted Psychotherapy: The Next Frontier, offers healthcare professionals a comprehensive overview of the emerging field of PAP. Attendees will gain knowledge of classical and novel psychedelic agents, as well as an understanding of what PAP entails. They will also learn about various models of psychotherapy that may support PAP and the principles of harm reduction, and a trauma-informed approach.
Delivered by Cambridge Health Alliance, this course is specifically designed for Primary Care Physicians, Specialty Physicians, Psychologists, Social Workers, and Counsellors. However, it may also interest those practicing in related fields such as Family Medicine, Internal Medicine, Lifestyle and Mind-Body Medicine, Psychiatry and Neurology, and Psychology and Mental Health.
The course starts at $175 and qualifies for CE and CME credits. Currently, the course is not being offered.
Find More Info on Psychedelic-Assisted Psychotherapy: The Next Frontier on PsychedelicsCourses.com
Harvard is working with Mass General and their team at the Center for the Neuroscience of Psychedelics. Harvard Law School recently launched their POPLAR initiative.